196 related articles for article (PubMed ID: 31758803)
1. Organs-on-Chips in Clinical Pharmacology: Putting the Patient Into the Center of Treatment Selection and Drug Development.
Peck RW; Hinojosa CD; Hamilton GA
Clin Pharmacol Ther; 2020 Jan; 107(1):181-185. PubMed ID: 31758803
[TBL] [Abstract][Full Text] [Related]
2. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
Cavero I; Guillon JM; Holzgrefe HH
Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
[TBL] [Abstract][Full Text] [Related]
3. Human organ chips for regenerative pharmacology.
Goyal G; Belgur C; Ingber DE
Pharmacol Res Perspect; 2024 Feb; 12(1):e01159. PubMed ID: 38149766
[TBL] [Abstract][Full Text] [Related]
4. Organs-on-chips technologies - A guide from disease models to opportunities for drug development.
Monteduro AG; Rizzato S; Caragnano G; Trapani A; Giannelli G; Maruccio G
Biosens Bioelectron; 2023 Jul; 231():115271. PubMed ID: 37060819
[TBL] [Abstract][Full Text] [Related]
5. Developmentally inspired human 'organs on chips'.
Ingber DE
Development; 2018 May; 145(16):. PubMed ID: 29776965
[TBL] [Abstract][Full Text] [Related]
6. Human microphysiological systems for drug development.
Roth A;
Science; 2021 Sep; 373(6561):1304-1306. PubMed ID: 34529479
[TBL] [Abstract][Full Text] [Related]
7. Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs.
Kaspera R; Shitara Y
AAPS J; 2024 Jun; 26(4):71. PubMed ID: 38886275
[TBL] [Abstract][Full Text] [Related]
8. A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.
Bai JPF; Earp JC; Strauss DG; Zhu H
CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):675-677. PubMed ID: 33159491
[No Abstract] [Full Text] [Related]
9. Emerging Role of Organ-on-a-Chip Technologies in Quantitative Clinical Pharmacology Evaluation.
Isoherranen N; Madabushi R; Huang SM
Clin Transl Sci; 2019 Mar; 12(2):113-121. PubMed ID: 30740886
[TBL] [Abstract][Full Text] [Related]
10. Introducing an automated high content confocal imaging approach for Organs-on-Chips.
Peel S; Corrigan AM; Ehrhardt B; Jang KJ; Caetano-Pinto P; Boeckeler M; Rubins JE; Kodella K; Petropolis DB; Ronxhi J; Kulkarni G; Foster AJ; Williams D; Hamilton GA; Ewart L
Lab Chip; 2019 Jan; 19(3):410-421. PubMed ID: 30663729
[TBL] [Abstract][Full Text] [Related]
11. Systems pharmacology modeling: an approach to improving drug safety.
Bai JP; Fontana RJ; Price ND; Sangar V
Biopharm Drug Dispos; 2014 Jan; 35(1):1-14. PubMed ID: 24136298
[TBL] [Abstract][Full Text] [Related]
12. 18th world congress of basic and clinical pharmacology: thought-provoking lectures on drug safety issues.
Cavero I; Holzgrefe HH
Expert Opin Drug Saf; 2019 Dec; 18(12):1145-1148. PubMed ID: 31566014
[No Abstract] [Full Text] [Related]
13. Human organs-on-chips for disease modelling, drug development and personalized medicine.
Ingber DE
Nat Rev Genet; 2022 Aug; 23(8):467-491. PubMed ID: 35338360
[TBL] [Abstract][Full Text] [Related]
14. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
15. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
[TBL] [Abstract][Full Text] [Related]
16. How viable are alternatives to animal testing in determining the toxicities of therapeutic drugs?
Balls M; Bailey J; Combes RD
Expert Opin Drug Metab Toxicol; 2019 Dec; 15(12):985-987. PubMed ID: 31735089
[No Abstract] [Full Text] [Related]
17. Model-Informed Drug Development: Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics.
Venkatakrishnan K; van der Graaf PH
Clin Pharmacol Ther; 2021 Nov; 110(5):1147-1154. PubMed ID: 34658027
[No Abstract] [Full Text] [Related]
18. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.
Venkatakrishnan K; Yalkinoglu O; Dong JQ; Benincosa LJ
Clin Pharmacol Ther; 2020 Oct; 108(4):699-702. PubMed ID: 32356569
[TBL] [Abstract][Full Text] [Related]
19. Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends.
Liu Q; Ahadpour M; Rocca M; Huang SM
AAPS J; 2021 Apr; 23(3):54. PubMed ID: 33846878
[TBL] [Abstract][Full Text] [Related]
20. Organs-on-chips: research and commercial perspectives.
Balijepalli A; Sivaramakrishan V
Drug Discov Today; 2017 Feb; 22(2):397-403. PubMed ID: 27866008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
